Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Frontier Vapor
WARNING LETTER
•Frontier Vapor•June 2, 2020

FDA WARNING_LETTER - Frontier Vapor - June 02, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Frontier Vapor
Record Details

On May 22, 2020, the FDA's Center for Tobacco Products issued a Warning Letter to Frontier Vapor after reviewing their website, https://frontiervapor.com. The FDA determined that several e-liquid products advertised and sold on the website are tobacco products under section 201(rr) of the FD&C Act.

The primary violation identified is that the advertising for e-liquid products, including "Northern Lights Vapor Co. - $100 Apple Pie," "Aetherium Piña," "Frontier Vapor - Chocolate Creampuff," "Frontier Vapor – Hypnozone," and "Hop Harvest Citra/Cascade April 2014 Reissue," fails to include the required nicotine warning statement: "WARNING: This product contains nicotine. Nicotine is an addictive chemical." This omission renders the products misbranded under sections 903(a)(7)(B) and 903(a)(7)(A) of the FD&C Act, violating 21 CFR 1143.3(b). The FDA considers the lack of this material fact in advertising to be misleading.

Frontier Vapor is required to immediately correct these violations and ensure all tobacco products, labeling, and advertising comply with the FD&C Act and FDA regulations across all platforms. Failure to comply may result in further FDA action, including civil money penalties, no-tobacco-sale orders, criminal

Company
Frontier Vapor
Inspection Date
June 2, 2020
Product Type
Tobacco
Office
Center for Tobacco Products
Person
  • Ann Simoneau (Director)
Open in Dashboard

ID · 7d9f78f4-1181-4324-92c1-09119af2aaaf

Violation Codes10
21 U.S.C. 321(rr)21 U.S.C. 387a(b)21 U.S.C. 387c(a)(7)(B)21 U.S.C. 387c(a)(7)(A)21 U.S.C. 321(n)21 CFR 1143.3(b)21 CFR 1143.3(b)(1)21 CFR 1143.3(b)(2)21 CFR 1143.121 CFR 1100.2

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.